Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

VNDA holding history

Vanda Pharmaceuticals Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VNDA overviewAll 13F holders of VNDAFull Q2 2026 holdings

Shares (Q2 2026)
3,441,361
Value
$21.1M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VNDA by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,441,361$21.1M<0.1%−318,198−8.5%ReducedHolders
Q1 20263,759,559$26.0M<0.1%+378,598+11.2%AddedHolders
Q4 20253,380,961$29.8M<0.1%−95,964−2.8%ReducedHolders
Q3 20253,476,925$17.3M<0.1%+29,465+0.9%AddedHolders
Q2 20253,447,460$16.3M<0.1%−118,965−3.3%ReducedHolders
Q1 20253,566,425$16.4M<0.1%−287,374−7.5%ReducedHolders
Q4 20243,853,799$18.5M<0.1%−157,723−3.9%ReducedHolders
Q3 20244,011,522$18.8M<0.1%−102,603−2.5%ReducedHolders
Q2 20244,114,125$23.2M<0.1%−161,500−3.8%ReducedHolders
Q1 20244,275,625$17.6M<0.1%+594,500+16.1%AddedHolders
Q4 20233,681,125$15.5M<0.1%+415,100+12.7%AddedHolders
Q3 20233,266,025$14.1M<0.1%+153,958+4.9%AddedHolders
Q2 20233,112,067$20.5M<0.1%+176,842+6.0%AddedHolders
Q1 20232,935,225$19.9M<0.1%+45,800+1.6%AddedHolders
Q4 20222,889,425$21.4M<0.1%−405,808−12.3%ReducedHolders
Q3 20223,295,233$32.6M<0.1%−341,200−9.4%ReducedHolders
Q2 20223,636,433$39.6M<0.1%+427,819+13.3%AddedHolders
Q1 20223,208,614$36.3M<0.1%−3,600−0.1%ReducedHolders
Q4 20213,212,214$50.4M0.1%−70,108−2.1%ReducedHolders
Q3 20213,282,322$56.3M0.1%−28,600−0.9%ReducedHolders
Q2 20213,310,922$71.2M0.1%−375,558−10.2%ReducedHolders
Q1 20213,686,480$55.4M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.